Debruyne FM - Search Results

1

Neoadjuvant therapy in prostate cancer--is it of any use?

Witjes WP, Horenblas S, Oosterhof GO, Schaafsma HE, Debruyne FM. Witjes WP, et al. Among authors: debruyne fm. Eur Urol. 1993;24(4):433-7. doi: 10.1159/000474346. Eur Urol. 1993. PMID: 8287884 Review.

2

In vivo effects of high energy shock waves on urological tumors: an evaluation of treatment modalities.

Oosterhof GO, Smits GA, de Ruyter AE, Schalken JA, Debruyne FM. Oosterhof GO, et al. Among authors: debruyne fm. J Urol. 1990 Sep;144(3):785-9. doi: 10.1016/s0022-5347(17)39592-7. J Urol. 1990. PMID: 2388350

3

Current status of neoadjuvant therapy in localized prostate cancer.

Witjes WP, Oosterhof GO, Schaafsma HE, Debruyne FM. Witjes WP, et al. Among authors: debruyne fm. Prostate. 1995 Dec;27(6):297-303. doi: 10.1002/pros.2990270602. Prostate. 1995. PMID: 7501541 Review. No abstract available.

4

The value of neoadjuvant therapy in localized prostate cancer.

Witjes WP, Oosterhof GO, Schaafsma HE, Debruyne FM. Witjes WP, et al. Among authors: debruyne fm. Int J Urol. 1995 Mar;2(1):1-5. doi: 10.1111/j.1442-2042.1995.tb00611.x. Int J Urol. 1995. PMID: 7614403 Free article. Review. No abstract available.

5

Computer analysis of transrectal ultrasound images of the prostate for the detection of carcinoma: a prospective study in radical prostatectomy specimens.

Giesen RJ, Huynen AL, Aarnink RG, de la Rosette JJ, vd Kaa C, Oosterhof GO, Debruyne FM, Wijkstra H. Giesen RJ, et al. Among authors: debruyne fm. J Urol. 1995 Oct;154(4):1397-400. J Urol. 1995. PMID: 7658546 Clinical Trial.

6

Risk factors in carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.

van Gils-Gielen RJ, Witjes WP, Caris CT, Debruyne FM, Witjes JA, Oosterhof GO. van Gils-Gielen RJ, et al. Among authors: debruyne fm. Urology. 1995 Apr;45(4):581-6. doi: 10.1016/s0090-4295(99)80047-8. Urology. 1995. PMID: 7716838 Clinical Trial.

7

A multicentre trial of combined neoadjuvant androgen blockade with Zoladex and flutamide prior to radical prostatectomy in prostate cancer. The European Study Group on Neoadjuvant Treatment.

Debruyne FM, Witjes WP, Schulman CC, van Cangh PJ, Oosterhof GO. Debruyne FM, et al. Eur Urol. 1994;26 Suppl 1:4. doi: 10.1159/000475423. Eur Urol. 1994. PMID: 7737257 Clinical Trial. No abstract available.

8

Overview of current status of total androgen deprivation in metastasized prostate cancer.

Debruyne FM, Witjes WP. Debruyne FM, et al. Eur Urol. 1993;24 Suppl 2:67-71. Eur Urol. 1993. PMID: 8262129 Review.

9

Overview of the current status of total androgen deprivation in metastasized prostate cancer.

Debruyne FM, Witjes WP. Debruyne FM, et al. World J Urol. 1993;11(4):233-6. doi: 10.1007/BF00185076. World J Urol. 1993. PMID: 8312942 Review. No abstract available.

10

Urodynamic and clinical effects of terazosin therapy in patients with symptomatic benign prostatic hyperplasia.

Witjes WP, Rosier FW, de Wildt MJ, van Iersel MP, Debruyne FM, de La Rosette JJ. Witjes WP, et al. Among authors: debruyne fm. J Urol. 1996 Apr;155(4):1317-23. J Urol. 1996. PMID: 8632523 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

669 results

Search Page

Filters